Sun Pharma Clarifies On Its Corporate Governance Issue
Sun Pharmaceutical Industries Ltd today made a press release, today, in order to clarify the ongoing corporate governance issue. Sun Pharma explained that the loan...
Tag : sun pharma
Pharmaceutical Majors Recall Their Products From USA
According to the latest U.S. Food and Drug Administration’s (USFDA) Enforcement Report, Indian pharma major such as Lupin, Sun Pharma and Glenmark has decided to...
Sun Pharma Outlook for the Week (Jan 21, 2019 – Jan 25, 2019)
EquityPandit’s Outlook for Sun Pharma for the week (Jan 21, 2019 – Jan 25, 2019) : SUN PHARMA: SUN PHARMA closed the week on negative note losing...
Sun Pharma Outlook for the Week (Jan 14, 2019 – Jan 18, 2019)
EquityPandit’s Outlook for Sun Pharma for the week (Jan 14, 2019 – Jan 18, 2019) : SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
Sun Pharma Outlook for the Week (Jan 07, 2019 – Jan 11, 2019)
EquityPandit’s Outlook for Sun Pharma for the week (Jan 07, 2019 – Jan 11, 2019) : SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
Sun Pharma Outlook for the Week (Dec 31, 2018 – Jan 04, 2019)
EquityPandit’s Outlook for Sun Pharma for the week (Dec 31, 2018 – Jan 04, 2019) : SUN PHARMA: SUN PHARMA closed the week on absolutely flat note....
Sun Pharma Receives Relief From US District Court Of Massachusetts
DUSA Pharmaceuticals, a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. has received relief from a U.S. court in a patent infringement case. According to...
Sun Pharma Outlook for the Week (Dec 24, 2018 – Dec 28, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Dec 24, 2018 – Dec 28, 2018) : SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
Sun Pharma Outlook for the Week (Dec 17, 2018 – Dec 21, 2018)
EquityPandit’s Outlook for Sun Pharma for the week (Dec 17, 2018 – Dec 21, 2018) : SUN PHARMA: SUN PHARMA closed the week on positive note gaining...
SEBI Examining The Complaint Against Sun Pharma’s Dilip Shanghvi
SEBI has announced that it is examining the whistleblower complaint against Dilip Shanghvi, CEO and Managing Director of Sun Pharmaceutical Industries. SEBI Chairman Ajay Tyagi...